HCRT and Obesity: A suggested mechanism for the involvement of orexin in the pathogenesis of obesity may lie in its actions on brown adipose tissue (BAT) (20, 25–27), a calorie-burning fat typically associated with newborns although its presence and metabolic activity has more recently also been verified in adulthood (28, 29).